Please Sign In

Kunming Biomed International (KBI), located in southwest China, is a CRO providing preclinical research services specialized on non-human primates. The core competency of KBI stems from our expertise in developing and running specialized primate animal models to test drug candidates and medical devices for their pharmacological effects and biocompatible repairs. A large animal colony combined with experienced research and scientific study teams can offer “one-stop service” which ensures quality and detail. We also conduct adjacency studies in PK/PD, in vivo pharmacology and preliminary toxicology. KBI offers cost effective study of the highest quality while applying the highest standards of animal welfare and animal ethics. KBI has already achieved AAALAC accreditation, and is working under GLP conditions.